Snake venom phospholipase A2s (Asp49 and Lys49) induce mechanical allodynia upon peri-sciatic administration: involvement of spinal cord glia, proinflammatory cytokines and nitric oxide
- 1 March 2004
- journal article
- Published by Wolters Kluwer Health in Pain
- Vol. 108 (1) , 180-191
- https://doi.org/10.1016/j.pain.2003.12.023
Abstract
Tory phospholipases A2 (sPLA2), corresponding to Asp49 and Lys49 PLA2s, have been isolated from Bothrops asper venom. These sPLA2s induce hyperalgesia in rats following subcutaneous injection. However, venom in natural Bothrops bites is frequently delivered intramuscularly, thereby potentially reaching peripheral nerve bundles. Thus, the present series of experiments tested whether these sPLA2s could exert pain-enhancing effects following administration around healthy sciatic nerve. Both were found to produce mechanical allodynia ipsilateral to the injection site; no thermal hyperalgesia was observed. As no prior study has examined potential spinal mechanisms underlying sPLA2 actions, a series of anatomical and pharmacological studies were performed. These demonstrated that both sPLA2s produce activation of dorsal horn astrocytes and microglia that is more prominent ipsilateral to the site of injection. As proinflammatory cytokines and nitric oxide have each been previously implicated in spinally mediated pain facilitation, the effect of pharmacological blockade of these substances was tested. The results demonstrate that mechanical allodynia induced by both sPLA2s is blocked by interleukin-1 receptor antagonist, anti-rat interleukin-6 neutralizing antibody, the anti-inflammatory cytokine interleukin-10, and a nitric oxide synthesis inhibitor (l-NAME). As a variety of immune cells also produce and release sPLA2s during inflammatory states, the data may have general implications for the understanding of inflammatory pain....Keywords
This publication has 55 references indexed in Scilit:
- GLIA: A novel drug discovery target for clinical painNature Reviews Drug Discovery, 2003
- Phospholipase A2 enzymesProstaglandins & Other Lipid Mediators, 2002
- A nitric oxide synthesis inhibitor (L-NAME) reduces licking behavior and Fos-labeling in the spinal cord of rats during formalin-induced inflammationPAIN®, 1996
- l-NAME, an inhibitor of nitric oxide synthase, blocks the established allodynia induced by intrathecal administration of prostaglandin E2Neuroscience Letters, 1995
- Human Neutrophils Store Type II 14-kDa Phospholipase A2 in Granules and Secrete Active Enzyme in Response to Soluble StimuliBiochemical and Biophysical Research Communications, 1995
- Intracellular Messengers Contributing to Persistent Nociception and Hyperalgesia Induced by L‐Glutamate and Substance P in the Rat Formalin Pain ModelEuropean Journal of Neuroscience, 1994
- A role for reactive oxygen species in zymosan and β-glucan induced protein tyrosine phosphorylation and phospholipase A2 activation in murine macrophagesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1994
- Roles of PMN Leucocytes, Platelets and Some Mediators in Rat Hind-paw Oedema Induced by Two Phospholipase A2 Enzymes From Trimeresurus mucrosquamatus VenomJournal of Pharmacy and Pharmacology, 1992
- A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesiaPAIN®, 1988
- Ethical guidelines for investigations of experimental pain in conscious animalsPAIN®, 1983